Monash University has a PhD opportunity in collaboration with the Department of Infectious Diseases Monash Health. This is a project to increase international contributions to the Antiretroviral Pregnancy Registry.
An exciting opportunity is available for a suitable PhD candidate with a nursing, medicine or allied health degree. We are seeking a PhD candidate with an interest in research focused on HIV, pregnancy and improving the quality of antiretroviral prescribing and safety reporting globally. This project, to be commenced in 2022, has been funded through the Gilead BRAVVO – HIV Treatment RFP Program. This grant will provide income support for the first year with the expectation of a research scholarship to support the 2nd and 3rd years.
Given the exclusion of pregnant women from most trials of antiretroviral therapy, the Antiretroviral Pregnancy Registry (APR) is often the most comprehensive source of safety information available and is used by clinicians globally. However, 70-80% of reports to the APR are from the United States and therefore do not reflect the global experience of antiretroviral use in pregnancy. This project seeks to increase awareness of the APR amongst HIV clinicians in Australia and to increase reporting to the APR from Australia as an example of what may be achievable internationally by trialling an innovative model harnessing the role of pharmacists across a number of sites in Australia.
Minimum entry requirements can be found here: https://www.monash.edu/admissions/entry-requirements/minimum